BIOLASE, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022
January 18, 2023 at 04:30 pm IST
Share
BIOLASE, Inc. provided revenue guidance for the fourth quarter and full year 2022. For the quarter, the company expects revenue in the range of $14.0 million and $14.4 million, reflecting a 13% to 16% increase over the fourth quarter of 2021.
For the year, the company expects revenue in the range of $48.4 million to $48.8 million, representing 24% to 25% growth over 2021.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
BIOLASE, INC. 
